| Jun 25 |
Aquestive Therapeutics Reports Positive Topline Data from Temperature / pH Study of Anaphylm™ (epinephrine) Sublingual Film
|
| Jun 19 |
Investors in Aquestive Therapeutics (NASDAQ:AQST) have unfortunately lost 36% over the last five years
|
| Jun 18 |
Aquestive Therapeutics to join Russell 3000 and Russell 2000 indexes
|
| Jun 18 |
Aquestive Therapeutics to Join the Russell 3000® and Russell 2000® Indexes Effective June 28, 2024
|
| Jun 3 |
Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities
|
| May 28 |
Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy Conference
|
| May 24 |
5 Small Drug Stocks to Buy From a Recovering Industry
|
